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Abstract
Introduction: Cardiac surgery is associated with post-operative reductions of functional residual capacity (FRC).
Manual hyperinflation (MH) aims to prevent airway plugging, and as such could prevent the reduction of FRC after
surgery. The main purpose of this study was to determine the effect of MH on post-operative FRC of cardiac
surgical patients.
Methods: This was a randomized controlled trial of patients after elective coronary artery bypass graft and/or valve
surgery admitted to the intensive care unit (ICU) of a university hospital. Patients were randomly assigned to a
“routine MH group” (MH was performed within 30 minutes after admission to the ICU and every 6 hours thereafter,
and before tracheal extubation), or a “control group” (MH was performed only if perceptible (audible) sputum was
present in the larger airways causing problems with mechanical ventilation, or if oxygen saturation (SpO2) dropped
below 92%). The primary endpoint was the reduction of FRC from the day before cardiac surgery to one, three,
and five days after tracheal extubation. Secondary endpoints were SpO2 (at similar time points) and chest
radiograph abnormalities, including atelectasis (at three days after tracheal extubation).
Results: A total of 100 patients were enrolled. Patients in the routine MH group showed a decrease of FRC on the
first post-operative day to 71% of the pre-operative value, versus 57% in the control group (P = 0.002). Differences
in FRC became less prominent over time; differences between the two study groups were no longer statistically
significant at Day 5. There were no differences in SpO2 between the study groups. Chest radiographs showed
more abnormalities (merely atelectasis) in the control group compared to patients in the routine MH group (P =
0.002).
Conclusions: MH partly prevents the reduction of FRC in the first post-operative days after cardiac surgery.
Trial registration: Netherlands Trial Register (NTR): NTR1384. http://www.trialregister.nl
Introduction
Pulmonary dysfunction is a ubiquitous consequence of
cardiac surgery [1]. Alterations in mechanical properties
of the lung lead to reductions in pulmonary compliance
[2] as well as vital and functional residual capacity
(FRC) [3,4] in the first days after surgery. In addition,
these patients remain sedated and are nursed in a
supine position for several hours, while they are re-
warmed and weaned from mechanically ventilation. This
may reduce mucociliary transport, and as such retention
of sputum [5,6]
In our setting, a frequently performed intervention as
part of airway management of intubated and mechani-
cally ventilated patients is manual hyperinflation (MH)
[7-9]. MH aims at mobilization of retained airway
secretions in intubated and mechanically ventilated
patients, thereby preventing atelectasis [10,11]. With
MH the patient is disconnected from the mechanical
ventilator, after which the lungs are inflated via a
resuscitation bag. The technique consists of several
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any medium, provided the original work is properly cited.factors, including the application of a larger than nor-
mal breath (to 150% of the tidal volume delivered by
the mechanical ventilator), the use of a slow inspira-
tory flow rate (achieved by a slow compression of the
resuscitation bag), an inspiratory pause (allowing com-
plete distribution of the inflated air among all the ven-
tilated lung parts) and a high peak expiratory flow
achieved by the rapid release of the resuscitation bag.
It is imaginable that a higher expiratory than inspira-
tory flow promotes the outwardly directed motion of
airway secretions [12,13].
Although mobilization of airway secretions and pre-
vention of sputum plugging [11,14], and improved
alveolar recruitment [10] are cited as potential benefits
of bagging, the evidence supporting its efficacy is
lacking.
We hypothesized MH to benefit cardiac surgery
patients. Specifically, we hypothesized MH maneuvers to
attenuate the reduction of FRC, to prevent hypoxemia
and to prevent atelectasis after cardiac surgery. To test
this hypothesis we designed a randomized controlled
trial to compare a strategy using frequent MH maneu-
vers with a strategy only using MH if clinically
indicated.
Materials and methods
Patients and setting
This trial was conducted from February 2009 to March
2010 at the 28-bed intensive care unit (ICU) of the Aca-
demic Medical Center, Amsterdam, The Netherlands.
The Institutional Review Board approved the study. Pre-
operative informed consent was obtained from patients
scheduled for elective coronary artery bypass graft and/
o rv a l v es u r g e r y .F i g u r e1p r e s e n t sat i m e l i n ed e p i c t i n g
the trial interventions.
Pre-operative spirometry was performed within two
weeks before surgery by trained respiratory technicians
according to the latest recommendations [15]. Patients
after previous lung surgery or moderate to severe
chronic obstructive pulmonary disease (post-bronchodi-
lator forced expired volume in one second (FEV1) < 80%
predicted and the ratio of forced expiratory volume in
one second and forced capacity (FEV1/FVC ratio) < 0.7)
[16] were excluded from participation.
Patients who required repeated cardiac surgery within
48 hours after the index surgical procedure and patients
who required prolonged post-operative mechanical ven-
tilation (> 36 hours) were excluded from the analysis,
since it would be impossible to measure FRC in these
patients on the predefined time points.
Preoperative risk factors were scored with the Eur-
opean System for Cardiac Operative Risk Evaluation
score (the Euroscore), a scoring system used to predict
mortality among cardiac surgery patients [17].
Manual hyperinflation
Attending ICU nurses performed MH maneuvers using
a standard technique [18,19]. Preceding this randomized
controlled trial, all ICU nurses took part in an educa-
tional program that highlighted the several factors con-
sidered important in performing MH [20]. MH was
performed in the supine position within 30 minutes
after connection to the ICU ventilator, repeated every 6
hours and directly before tracheal extubation.
A Mapelson-C circuit with a two liter re-breathing bag
(Medicare, Uitgeest, The Netherlands) with the gas flow
entry and the expiratory valve located at the patient end
of the circuit (a standard bedside resuscitation and man-
ual hyperinflation circuit) was used to perform the man-
euver. The circuit was connected to wall oxygen at 15
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Figure 1 Time line depicting trial investigations and interventions. Note that time till tracheal extubation is variable among patients, as is
the number of manual hyperinflation maneuvers. Abbreviations: OR, operation room; ICU, intensive care unit; CXR, chest radiography; FRC,
functional residual capacity; MH, manual hyperinflation.
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Endotracheal suctioning was performed in sequence
with the MH-procedure to remove secretions if mobi-
lized by MH.
Randomization
On admission to the ICU, patients were randomly
assigned to a strategy using frequent MH maneuvers
(the “routine MH group”)o ras t r a t e g yu s i n gM Ho n l y
on clinical indication (the “control group”). Randomiza-
tion was by cards in opaque sealed envelopes drawn by
an independent person.
The “routine MH group": A MH maneuver was per-
formed within 30 minutes after connection to the ICU-
ventilator, repeated every 6 hours and directly before
tracheal extubation. In case of perceptible sputum
[21,22] which could not be removed from the larger air-
ways with endotracheal suctioning, or in case of a drop
in oxygen saturation (SpO2, < 95%), an additional MH
maneuver could be performed. It was left to the discre-
tion of the attending ICU nurse whether MH was
accompanied by tracheal suction.
The “control group": A MH maneuver was only per-
formed in case of perceptible sputum which could not
be removed from the larger airways with endotracheal
suctioning, or in case of a drop in SpO2 (< 95%).
Standard procedures
Independent anesthesiologists, ICU physicians and
nurses not involved in the study carried out standard
procedures.
Patients were anesthetized according to the institu-
tional protocol for cardiac surgery; pre-medication con-
sisted of 1 to 2 mg lorazepam and anesthesia was
induced by etomidate, sufentanil, and rocuronium. Dur-
ing the surgical procedure, sufentanil (150 to 250 micro-
grams) was used as an analgesic, and sevoflurane plus
propofol were used to maintain anesthesia. Morphine (5
mg) and midazolam (5 mg) were given at the end of the
procedure. The ventilatory protocol consisted of
volume-controlled ventilation with a tidal volume of 6
to 8 ml/kg, at an inspired oxygen fraction of 0.40, posi-
tive end expiratory pressure of 5 cmH20, inspiratory-to-
expiratory ratio of 1:2, and a respiratory rate adjusted to
achieve normocapnia. Cardiopulmonary bypass was per-
formed under moderate hypothermia (32°C), using a
membrane oxygenator and non-pulsatile blood flow. At
the end of anesthesia, all patients were transferred to
the ICU with tracheal intubation.
The post-operative ICU protocol involved fluid resus-
citation with normal saline and starch solutions, blood
transfusion to maintain hemoglobin concentration ≥ 5.0
mmol/L, dopamine and norepinephrine in continuous
infusion to achieve mean arterial blood pressure ≥ 70
mmHg, and dobutamine and/or enoximone to achieve a
cardiac index ≥ 2.5 L/minute/m
2 or a mixed venous
oxygenation ≥ 60%.
Sedation and analgesics were titrated according to the
ICU protocol for cardiac surgery patients. Neuromuscu-
lar blocking drugs were never used in the ICU. Propofol
was given for sedation via continuous infusion until the
core temperature was ≥ 36.0°C. Acetaminophen (4 g/
day) was started in all patients. Attending ICU nurses
assessed requirement for analgesia during the entire
ICU stay. Morphine was given in boluses of 1 to 2 mg,
and repeated as needed.
The trachea was extubated after achieving general tra-
cheal extubation criteria (that is, responsive and coop-
erative, hemodynamic stability, chest tube drainage <
100 mL last hour, having a rectal temperature > 36.0°C,
a respiratory frequency of 10 to 20 breaths/minute with-
out machine-controlled breaths, FiO2 of 40%, and a
pressure support level of 5 to 10 cmH2Of o r3 0m i n -
utes). After extubation oxygen was administered to the
nostrils, typically 3 to 5 L/minute. If PaO2 was > 100
mmHg (13.3 kPa), administration of oxygen was step-
wise reduced to 1 L/minute.
All patients were mobilized early, and had daily rou-
tine chest physiotherapy. On the first or second post-
operative day, patients were discharged from the ICU
and transferred to an intermediate care unit.
Primary endpoint
The primary endpoint was the change of FRC from the
day before cardiac surgery to one, three, and five days
after tracheal extubation. FRC measurements were per-
formed with use of the “He re-breathing technique”
(Masterscreen-PFT; Jaeger, Wurzberg, Germany) accord-
ing to the European Respiratory Society recommenda-
tions [23]. During FRC measurements, patients were
breathing room air while in bed in the upright sitting
position. The mean value of 2 technical acceptable mea-
surements was recorded. All measurements were per-
formed by the same investigator recorded who was
blinded for randomization groups.
Secondary endpoints
Pulse-oximeter oxygen saturation (SpO2) was mea-
sured with commercial pulse- oximeters (IntelliVue
pulse-oxymetrie; Philips, Eindhoven, The Netherlands;
or Datascope ‘Duo’ with Masimo SET
®,H o e v e l a k e n ,
The Netherlands) during the first five days after tra-
cheal extubation. SpO2 was measured for 10 minutes
while the patient was breathing room air. Measure-
ments were terminated when SpO2 dropped to a level
≤90%. The latter was defined as hypoxemia, and sup-
plemental oxygen therapy was continued with its
occurrence.
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both pre-operative and on the third post-operative day.
An independent radiologist blinded for randomization
groups interpreted the chest radiographs. Each radio-
graph was evaluated for the presence of atelectasis, pul-
monary infiltrate, extra-vascular lung fluid, pleural fluid,
and pneumothorax. The presence of atelectasis was
graded as: no atelectasis ("0”); plate or sub-segmental
atelectasis ("1”); segmental atelectasis ("2”); or lobair
atelectasis ("3”); for the purpose of this study, extent of
other abnormalities was graded as: not present ("0”);
mild ("1”); moderate ("2”); or severe ("3”).
Other data collected
These included the number of MH maneuvers per
patient; demographics (age, gender, body weight, body
height, type of surgery), duration of anesthesia, anes-
thetics given to the patient during surgery, duration
until tracheal extubation and length of stay in ICU and
hospital, propofol and morphine dose in the ICU.
Power calculation
This trial was designed to detect a 300 mL difference in
the post-operative FRC between the two study groups
(10). A sample size of 42 in each group would have 80%
power to detect a difference in means of -300 mL (the
difference between a Group 1 mean, of 1.900 mL and a
Group 2 mean, of 2.200 mL), assuming that the FRC
standard deviation was 480 mL using analysis of var-
iance (ANOVA) for repeated measurements with a 0.05
two-sided significance level. Based on an anticipated
drop-out of 15 to 20% we randomized a total of 100
patients.
Statistical analysis
Data were presented as mean with standard deviation
(SD) or medians with interquartile range (IQR) where
appropriate. Descriptive statistics were used to summar-
ize patient characteristics. Differences in FRC and SpO2
at the different time points were compared by analysis
of variance (ANOVA) for repeated measurements. Cate-
gorical variables (hypoxic periods, chest radiograph data
and MH data) were compared between groups by X
2
tests. All participants were analyzed in the groups that
they were allocated to. The level of significance was set
at 0.05. All analyses were performed using SPSS for
Windows (version 18.0, SPSS Inc., Chicago, IL, USA).
Results
One hundred patients were randomly assigned to one of
the two groups (Figure 2). Seven patients (four in the
routine MH group and three in the control group) were
not analyzed because they needed repeated cardiac sur-
gery. In nine patients (six in the routine MH group and
three in the control group) FRC measurements could
not be performed on predefined time points because of
tracheal extubation > 48 hours or re-intubation for car-
diac instability (10). In three other patients, (one in the
r o u t i n eM Hg r o u pa n dt w oi nt h ec o n t r o lg r o u p ) ,F R C
measurements could not be performed on predefined
time points because of tracheal extubation > 48 hours
because of respiratory failure (2).
Two patients died; one patient in the routine MH
group died of bowel ischemia after four days; one
patient in the control group died due to cardiac failure.
Groups were comparable for all demographic data
(Table 1). No differences were found for time till tra-
cheal extubation or stay in ICU or hospital. Adminis-
tered analgesics, sedatives and blood products were
similar between groups. Ventilator data are given in
Table 2
MH maneuvers
Patients in the routine MH group received median
(IQR) 2 (2 to 3) MH maneuvers compared to 0 (0 to 0)
in the control group (P < 0.001). Endotracheal suction
was performed 2.5 (2 to 4) times in the patients in the
routine MH group compared to 1 (1 to 2) in the
patients in the control group (P < 0.001).
Changes in FRC
In both groups, FRC was significantly reduced after car-
diac surgery (from 2.840 ml ± 720 to 1,815 ml ± 540
ml, difference = 1.025 ml, 95% CI 877 to 1,176 ml, P <
0.001) (Figure 3).
In the routine MH group FRC decreased on the first
post operative day to 71% of the pre-operative value
(from 2.875 ± 565 mL to 2.055 ± 540 mL), while in the
control group FRC decreased to 57% of pre-operative
level (from 2.808 ± 650 mL to 1.588 ± 530 mL). The
difference was 400 mL, 95% CI 680 to 115 mL, P =
0.002).
The absolute reduction in FRC at Day 3 was lower in
the routine MH strategy group (750 ± 565 mL) com-
pared to the control group (1,056 ± 570 mL) (difference
= 306 mL, 95% CI 593 to 20 mL P = 0.04). Differences
in decreases of FRC between the two study groups were
no longer statistical significant at Day 5 (760 ± 500 mL
in the routine MH group and 730 ± 530 mL and the
control group, respectively).
Oxygenation
There were no differences between groups in PaO2/
FiO2, either within one hour after admission to the ICU
or during intubation and mechanical ventilation. Hypox-
emia on the first post-operative day occurred in 17% of
the patients in the MH group versus 28% of the patients
in the control group, at Day 3 in 13% in the MH group
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occurred in 8% of the patients in both groups. Differ-
ences did not reach statistical significance (Table 3).
Chest radiographs
Pre-operative chest radiographs showed no atelectasis.
At Day 3 more patients in the control group had atelec-
tasis compared to patients in the routine MH strategy
group (Table 4). However, there was no difference in
the atelectasis score between the two groups. Pneu-
mothorax was found in two patients, one in each study
group. A mild pulmonary infiltrate was found in one
patient in the routine MH group; moderate pulmonary
infiltrates were found in two patients, one in each study
group.
Discussion
The results of our randomized controlled trial can be
summarized as follows: (1) FRC is significantly reduced
in patients after cardiac surgery for several days; (2) MH
partly prevents this reduction; (3) the incidence of signs
of atelectasis on chest radiographs differed between
groups.
Our study is the first randomized controlled trial
assessing the effects of MH on FRC in patients after car-
diac surgery. Its findings are in line with the results of
other studies suggesting thatM Hm a yb e n e f i tp a t i e n t s
after surgery. A previous randomized controlled trial
showed early MH to improve PaO2 and static compli-
ance in patients after myocardial re-vascularisation [24].
Also, MH reduced duration of mechanical ventilation in
that trial. Another randomized controlled trial con-
firmed MH to improve oxygenation after surgery [25].
The reduction of FRC and thep r e s e n c eo fa t e l e c t a s i s
after cardiac surgery in our trial are consistent with
findings in previously published studies of cardiac sur-
gery patients. In one study deterioration of pulmonary
function was frequently seen after cardiac surgery, with
FRC reductions of 40 to 50% during the first 24 hours
after tracheal extubation [26]. Also, incidence of signs of
atelectasis on chest radiographs occurred in up to 90%
of patients after cardiac surgery, and its presence was
associated with a larger decrement in pulmonary func-
tion. In another study, atelectasis persisted for several
days after surgery, was likely to be a focus of infection
and could have been a contributing factor to pulmonary
complications [27].
Plugging of airway secretions may lead to airway
obstructions, thereby causing gas resorption distal to the
obstructions in patients who are mechanically ventilated.
Beneficial effects of MH on clearance of airway secretion
have been demonstrated before [14]. Higher expiratory
than inspiratory flows generated with MH is the pro-
posed mechanisms that contribute to clearance of
Figure 2 CONSORT diagram of the trial.
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lated patients. In accordance, in our study endotracheal
suction was performed more often in patients in the
routine group compared to patients who received on
demand MH, suggesting improved clearance of secre-
tions necessitating airway suctioning. Unfortunately, the
amount and appearance of eliminated secretions were
not compared between groups, which could be seen as a
limitation of our trial.
Our data suggest that MH could contribute to the recov-
ery of collapsed lung areas after cardiac surgery. Delivering
increased tidal volumes with an inspiratory pause via MH
could generate transpulmonary pressures that could over-
come, at least in part, alveolar collapses [28]. Earlier studies
concluded that for complete reopening of collapsed lung
tissue inspirations are required that reach airway pressures
of 40 cmH2O which are maintained for eight to nine sec-
onds [29]. Certainly, MH is not capable of providing such
pressures for longer than a few seconds. However, short-
lasting natural occurring maneuvers, such as coughing and
sighs, also result in recruiting of lung tissue.
Hypoxemia occurred in 23% of patients at Day 1 after
tracheal extubation. These findings were in contrast to
Table 1 Characteristics of the study population
Routine MH
(N = 50)
Control
(N = 50)
Demographics
Age, yrs 65 ± 10.2 60.3 ± 13.5
Male, n 35 38
BMI, kg/m
2 25.8 ± 4.2 26.7 ± 4.7
FEV1, % 95 ± 14 99 ± 16
FVC, % 101 ± 14 101 ± 15
EuroScore, % 5.4 ± 2.7 4.4 ± 2.8
Current smokers, n 14 10
Type of surgery
CABG, n 13 16
Valve surgery, n 29 24
Combined CABG/valve surgery, n 8 10
LIMA, n 20 22
Intra-operative and intensive care characteristics
Duration of surgery, minutes 305 ± 84 300 ± 73
CPB time, minutes 134 ± 58 128 ± 61
Total sufentanil dose, microgram 188 (143 to 250) 250 (150 to 250)
Total midazolam dose, mg 15 (9 to 20) 15 (5 to 25)
Total morphine dose, mg 21 (9 to 20) 15 (5 to 25)
Total propofol dose, mg 1.250 (785 to 1.800) 1.478 (1.060 to 2.010)
WBC on ICU admission (× 10
6) 1 0±3 1 0±3
Core temperature on ICU admission (°C) 35.7 ± 0.8 35.6 ± 0.9
Sedation duration (ICU), hours 3.9 (2.0 to 13.9) 3.5 (2.3 to 18.0)
Duration of tracheal intubation (ICU), hours 10.5 (6.5 to 16.0) 10.8 (7.3 to 24.6)
Length of stay (ICU), hours 23.2 (20.8 to 44.8) 23.2 (20.7 to 46.3)
Length of stay (hospital), days 5.3 (4.3 to 7.4) 5.4 (4.4 to 7.2)
Data are presented as mean ± SD or median (IQR).
Abbreviations: BMI, body mass index; CABG, coronary artery bypass graft; FEV1, forced expired volume in one second, expressed as percentage of predicted
value; FVC, vital capacity, expressed as percentage of predicted value; EuroScore, based on system predicting mortality with cardiac surgery (%); CPB, cardio
pulmonary bypass; LIMA, left internal mammary artery; WBC, white blood cell count.
Table 2 Respiratory data
Routine MH
(N = 46)
Control
(N = 47)
P-value
PEEP (cmH2O) OR 5 ± 0.1 5 ± 0.1 P = 0.90
ICU 5 ± 1 6 ± 2 P = 0.20
PIP (cmH2O) OR 16 ± 3 16 ± 3 P = 0.70
ICU 17 ± 3 18 ± 3 P = 0.15
Tidal volume (ml/kg IBW) OR 7.7 ±.1.2 7.4 ± 1.2 P = 0.20
ICU 7.9 ± 1.3 7.9 ± 1.3 P = 0.82
Maximum FiO2 OR 0.85 ± 0.17 0.82 ± 0.19 P = 0.43
ICU 0.53 ± 0.9 0.50 ± 0.17 P = 0.28
FiO2 OR 0.48 ± 0.12 0.48 ± 0.12 P = 0.87
ICU 0.47 ± 0.09 0.47 ± 0.07 P = 0.97
Data are presented as mean ± SD.
Abbreviations: PEEP, Positive End Expiratory Pressure; OR, Operating Room;
ICU, Intensive Care Unit; PIP, Positive Inspiratory Pressure; IBW, Ideal Body
weight; FiO2, Fraction of inspired oxygen.
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with hypoxic periods within the first two days after tra-
cheal extubation [26,30]. There are several possible
explanations as to why MH in our trial did not result in
a greater difference in the presence of hypoxemia. One
reason could be that oxygenation not only results from
changes in (regional) ventilation but also from changes
in (regional) perfusion. Hypoxic pulmonary vasocon-
striction may be responsible for maintaining the ventila-
tion-perfusion ratio during localized alveolar hypoxia.
Thus, if hypoxic pulmonary vasoconstriction works, oxy-
genation is preserved even during atelectasis. This could,
at least in part, explain our findings. Another reason
could have been the use of the pulse-oximeter to detect
hypoxemia. Although the pulse-oximeter is an device
with a reasonable degree of accuracy, the performance
of the pulse-oximeter can be disrupted by several,
including poor peripheral perfusion and peripheral vaso-
constriction [31]. We cannot exclude the possibility that
the pulse-oximeter was not discriminative enough. It
may be more plausible that our trial was insufficiently
powered to detect a difference in hypoxemia between
groups.
The incidence of signs of atelectasis on chest radio-
graphs differed between groups. Indeed, significantly
fewer patients in the routine MH group had radio-
graphic signs of atelectasis. Reasons for atelectasis after
cardiac surgery are multiple and include higher levels of
intra-operative FiO2, type of surgery, obesity and post-
operative pain. Absorption atelectasis during mechanical
FRC (L)
1.0
1.2
1.4
1.6
1.8
2.0
2.2
2.4
2.6
2.8
3.0
3.2
Pre-op day 1  day 3  day 5 
**
*
Figure 3 Measurements of functional residual capacity. Preoperative functional residual capacity (FRC (L) mean 95% CI) and FRC at one,
three and five days after tracheal extubation in routine MH (N = 37; closed symbols) and control group (N = 41; open symbols). *, P < 0.04, **, P
< 0.002.
Table 3 Clinical outcome data
routine MH group
(N = 46)
control group
(N = 47)
P-value
First PaO2/FiO2 (one hour after admission) (mmHg) 339 ± 127 329 ± 126 P = 0.70
Worst PaO2/FiO2, (while intubated and mechanically ventilated) (mmHg) 213 ± 70 221 ± 82 P = 0.60
Hypoxemia - Day 1 (n (%)) 8 (17) 13 (28) P = 0.23
Hypoxemia - Day 3 (n (%)) 6 (13) 10 (21) P = 0.29
Hypoxemia - Day 5 (n (%)) 3 (8) 3 (8) P = 0.60
SpO2 - Day 1 (%) 95 (93 to 97) 94 (90 to 97) P = 0.75
SpO2 - Day 3 (%) 95 (91 to 96) 94 (92 to 96) P = 0.75
SpO2 - Day 5 (%) 96 (94 to 97) 96 (95 to 97) P = 0.75
Data are presented as percentages of N (%), medians (IQR) or means ± SD. Hypoxemia was defined as a drop of SpO2 ≤90% within five minutes after cessation
of oxygen supply.
Abbreviations: SpO2, peripheral oxygen saturation; PaO2, partial pressure of arterial oxygen; FiO2, fraction of inspired oxygen.
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are high [27]. Indeed, higher levels of FiO2 during
mechanical ventilation because of general anesthesia
during surgery are associated with atelectasis formation
[27,32]. Another causative factor could be the harvesting
of the internal mammary artery [33]. Use of the internal
mammary artery graft has been found to be associated
with a greater occurrence of post-operative atelectasis.
Finally, post-operative pain leads to impairment of deep
breaths and, therefore, could enhance formation of
atelectasis [34]. The differences between groups could
not be explained by the above-mentioned factors, since
they affected both groups to the same extent.
MH may cause a short-term state of hyperinflation
and as such it can be questioned if MH is a safe proce-
dure. We, and others, have studied possible adverse
effects of MH [19,35,36]. These studies suggested that
MH, when performed under controlled conditions and/
or performed by experienced and trained nurses, has
negligible side-effects. In our previous experiences we
neither registered side-effects prospectively nor did we
evaluate patient comfort in the present trial.
We excluded patients who required prolonged post-
operative mechanical ventilation (> 36 hours) from analy-
sis of the primary endpoint, since it was impossible to
measure FRC in these patients on the predefined time
points. We explicitly intended to study post-extubation
changes in FRC, since FRC is affected by intubation and
mechanically ventilation, especially when positive end
expiratory pressure (PEEP) is applied (as was the case for
all these patients). The patients, who were excluded from
the analysis of the primary endpoint, were analyzed for
secondary endpoints. The analysis of the secondary end-
points supports the analysis of the primary endpoint.
We recognize several other limitations of our study.
First, the bedside FRC measurement is not the most
optimal technique for quantifying lung aeration. Fre-
quent computer tomography scanning, considered the
gold standard for quantifying lung aeration, however,
could not be performed for obvious reasons [37]. Never-
theless, recently bedside FRC measurement techniques
have been evaluated with acceptable accuracy and
repeatability [38]. In addition, in another study changes
in FRC after alveolar de- and re-recruitment could be
easily assessed [39]. A second limitation is that we did
not measure MH parameters considered important for
its efficacy. However, we recently showed that the
implementation of MH guidelines, guided by individual
feedback and educational meetings led to consistent
MH performance [20]. A third limitation considers gen-
eralizability of our findings. Our study was a single-cen-
ter trial, and practice may differ elsewhere. For instance,
tracheal intubation times in our cohort are different
from those reported elsewhere.
Conclusions
MH partly prevents reduction of FRC in patients after
cardiac surgery in the first post-operative days. In accor-
dance, the incidence of signs of atelectasis on post-opera-
tive chest radiographs is significant lower in patients who
receive MH. Future studies are needed to determine the
effect of MH on important clinical endpoints, including
duration of tracheal intubation, post-operative pulmon-
ary complications and duration of hospitalization.
Key messages
￿ In patients after cardiac surgery, reduction of FRC is
partly prevented by manual hyperinflation.
￿ The incidence of signs of atelectasis on post-opera-
tive chest radiographs in patients after cardiac surgery is
lower in patients who receive manual hyperinflation.
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